GlassScriptPhysician profile
Eva C Kim
NPI 1457401259
$94,961.36
in general payments reported to CMS, 2019-2025
35 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,174 · 2020: $451 · 2021: $2,289 · 2022: $12K · 2023: $11K · 2024: $37K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Food and Beverage: $9,880 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,225 · Travel and Lodging: $2,744 · Gift: $33.60 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,295.14 |
| Food and Beverage | $9,880.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,225.00 |
| Travel and Lodging | $2,743.99 |
| Gift | $33.60 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $50,665.02 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Clareon, Lensx |
| Rxsight INC | $27,247.24 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Alcon Research LLC | $8,730.85 | 2022-2024 | |
| Glaukos Corporation | $4,591.43 | 2020-2025 | Travoprost Intraocular Implant - Idose, Kxl System, Idosetr |
| Bausch & Lomb Americas INC. | $981.93 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Abbvie INC. | $557.08 | 2022-2024 | |
| Biotissue Holdings INC. | $447.65 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $200.94 | 2019-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $177.45 | 2024 | Tecnis Simplicity |
| Dompe US, INC. | $162.33 | 2019-2025 | Oxervate |
| Amgen INC. | $144.04 | 2024 | Tepezza |
| Carl Zeiss Meditec, INC. | $138.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $127.99 | 2020-2023 | |
| Sight Sciences, INC. | $127.47 | 2022 | |
| New World Medical,INC. | $87.33 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $59.77 | 2020-2024 | Dextenza |
| Thea Pharma INC. | $50.71 | 2022-2023 | Iyuzeh |
| Akorn, INC. | $47.26 | 2019 | |
| Staar Surgical Company | $46.88 | 2019 | |
| Mallinckrodt Hospital Products INC. | $45.45 | 2022 | |
| Allergan, INC. | $31.33 | 2019 | |
| Akorn Operating Company LLC | $31.17 | 2021 | |
| Lumibird Medical INC. | $28.20 | 2024 | |
| Shire North American Group INC | $24.48 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $23.25 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $22.43 | 2019 | |
| Aerie Pharmaceuticals, INC. | $21.83 | 2019 | |
| Horizon Therapeutics Plc | $21.15 | 2022 | |
| Coopervision INC. | $20.16 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Omeros Corporation | $18.82 | 2021 | |
| Eyepoint US, INC. | $18.07 | 2020 | |
| Travere Therapeutics, INC. | $16.69 | 2021 | |
| Mallinckrodt Enterprises LLC | $15.04 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.